Geburtshilfe Frauenheilkd 2013; 73(2): 142-147
DOI: 10.1055/s-0032-1328133
Original Article
Georg Thieme Verlag KG Stuttgart · New York

Use of the Sentinel Lymph Node Technique Compared to Complete Inguino-femoral Lymph Node Removal in Patients with Invasive Vulvar Cancer in Germany

Verbreitung der Sentinellymphknotentechnik im Vergleich zur kompletten inguinofemoralen Lymphknotenentfernung beim invasiven Vulvakarzinom in Deutschland
F. Kramer
1   Gynecology and Obstetrics, Medical School Hanover, Hanover
,
H. Hertel
1   Gynecology and Obstetrics, Medical School Hanover, Hanover
,
P. Hillemanns
1   Gynecology and Obstetrics, Medical School Hanover, Hanover
› Author Affiliations
Further Information

Publication History

received 26 June 2012
revised 31 October 2012

accepted 13 December 2012

Publication Date:
07 March 2013 (online)

Abstract

In the current S2 guidelines, the standard surgical therapy for patients with vulvar cancer also includes inguino-femoral lymphadenectomy. However, in view of the severe side-effects associated with this approach such as problems with wound healing, lymphoceles and lymphoedema, the search is on for alternative treatments that could decrease treatment-associated morbidity and improve patientsʼ quality of life, particularly for node-negative patients. The sentinel lymph node technique is currently the gold standard in the treatment of unifocal breast cancer (clinically negative axilla), and studies on the use of this technique in the treatment of vulvar cancer are promising. To date, the diagnostic accuracy of this method in vulvar cancer has only been evaluated in a single, one-arm, non-randomised, multicentre study. In preparation for a multicentre study, in 2010 we surveyed 41 German hospitals to investigate how often they used the sentinel lymph node technique compared to inguino-femoral lymphadenectomy. The hospitals were grouped according to hospital size and number of patients treated for vulvar cancer. The decision criteria to determine the type of procedure performed were also investigated. Finally, the hospitals were asked whether they would be willing to participate in a prospective clinical study to evaluate the sentinel lymph node technique in patients with vulvar cancer. The majority of surgeons questioned (73 %) already had some experience with this technique in patients with vulvar cancer. In our survey, 27 % of hospitals carried out inguino-femoral lymphadenectomy, 10 % used the sentinel lymph node technique, and 63 % used both methods. In 24 % of hospitals, the standard procedure consisted of the sentinel lymph node technique supplemented by inguino-femoral lymphadenectomy. Only 20 % of the institutions surveyed in our study carried out sentinel lymph node biopsy alone in accordance with the criteria of the consensus recommendations. The majority of the investigated institutions were willing to participate in a randomised prospective clinical study to evaluate the effectiveness of sentinel lymph node sampling in patients with vulvar cancer.

Zusammenfassung

Die inguinofemorale Lymphonodektomie stellt nach aktuellen Leitlinien das Standardverfahren beim Vulvakarzinom dar. Aufgrund erhöhter Raten an Wundheilungsstörungen, Lymphozelen und Lymphödemen könnten alternative Behandlungsmethoden insbesondere für nodalnegative Patientinnen zu einer Senkung der krankheitsassoziierten Morbidität und zu einer Steigerung der Lebensqualität führen. Die Sentinellymphonodektomie stellt beim unifokalen Mammakarzinom (klinisch unauffällige Axilla) den Goldstandard dar, und Studien zum Einsatz beim Vulvakarzinom weisen vielversprechende Ergebnisse auf. Bisher wurde in lediglich einer einarmigen, nicht randomisierten Studie die Wertigkeit dieser Methode überprüft. In einer Umfrage unter 41 deutschsprachigen Kliniken wurde 2010 die Verbreitung der Sentinellymphknotentechnik im Vergleich zur inguinofemoralen Lymphonodektomie erfasst. Die Kliniken wurden nach Größe und nach Anzahl der Vulvakarzinom-Patientinnen unterteilt. Erfasst wurde, welche Art der Lymphonodektomie nach welchen Entscheidungskriterien angewandt wird. Abschließend wurde die Bereitschaft zur Teilnahme an einer klinisch-prospektiven Studie zur Evaluation der Sentinellymphonodektomie beim Vulvakarzinom ermittelt. Die Mehrheit der Befragten (73 %) hatte Erfahrung mit dieser Technik beim Vulvakarzinom. In 27 % der Kliniken wurde die inguinofemorale, in 10 % die Sentinellymphonodektomie und in 63 % wurden beide Methoden angewandt. Eine Komplettierung der Sentinellymphknotentechnik wurde in 24 % der Kliniken grundsätzlich durchgeführt. Bei der Sentinellymphonodektomie gaben 20 % der Befragten an, gemäß Kriterien zu verfahren, die in den Konsensusempfehlungen empfohlen wurden. Die Mehrheit der befragten Kliniken würde an einer randomisierten klinisch-prospektiven Studie zur Evaluation der Wertigkeit der Sentinellymphonodektomie beim Vulvakarzinom teilnehmen.

 
  • References

  • 1 Hording U, Junge J, Daugaard S et al. Vulvar squamous cell carcinoma and papillomaviruses: indications for two different etiologies. Gynecol Oncol 1994; 52: 241
  • 2 Jones RW, Rowan DM. Vulvar intraepithelial neoplasia III: a clinical study of the outcome in 113 cases with relation to the later development of invasive vulvar carcinoma. Obstet Gynecol 1994; 84: 741
  • 3 Sturgeon SR, Brinton LA, Devesa SS et al. In situ and invasive vulvar cancer incidence trends (1973 to 1987). Am J Obstet Gynecol 1992; 166: 1482
  • 4 Iversen T, Tretli S. Intraepithelial and invasive squamous cell neoplasia of the vulva: trends in incidence, recurrence, and survival rate in Norway. Obstet Gynecol 1998; 91: 969
  • 5 Hacker NF, Leuchter RS, Berek JS et al. Radical vulvectomy and bilateral inguinal lymphadenectomy through separate groin incisions. Obstet Gynecol 1981; 58: 574
  • 6 Burger MP, Hollema H, Emanuels AG et al. The importance of the groin node status for the survival of T1 and T2 vulval carcinoma patients. Gynecol Oncol 1995; 57: 327
  • 7 Bell JG, Lea JS, Reid GC. Complete groin lymphadenectomy with preservation of the fascia lata in the treatment of vulvar carcinoma. Gynecol Oncol 2000; 77: 314
  • 8 Knopp S, Nesland JM, Trope C. SLNB and the importance of micrometastases in vulvar squamous cell carcinoma. Surg Oncol 2008; 17: 219
  • 9 Robison K, Steinhoff MM, Granai CO et al. Inguinal sentinel node dissection versus standard inguinal node dissection in patients with vulvar cancer: A comparison of the size of metastasis detected in inguinal lymph nodes. Gynecol Oncol 2006; 101: 24
  • 10 Rouzier R, Haddad B, Dubernard G et al. Inguinofemoral dissection for carcinoma of the vulva: effect of modifications of extent and technique on morbidity and survival. J Am Coll Surg 2003; 196: 442
  • 11 Gaarenstroom KN, Kenter GG, Trimbos JB et al. Postoperative complications after vulvectomy and inguinofemoral lymphadenectomy using separate groin incisions. Int J Gynecol Cancer 2003; 13: 522
  • 12 van der Zee AG, Oonk MH, de Hulla JA et al. Sentinel node dissection is safe in the treatment of early-stage vulvar cancer. J Clin Oncol 2008; 26: 884-889
  • 13 Malur S, Altgassen C, Ackermann S et al. Wertigkeit des Sentinellymphknotens in der gynäkologischen Onkologie. Geburtsh Frauenheilk 2003; 63: R185-R204
  • 14 Hampl M, Hantschmann P, Michels W et al. Validation of the accuracy of the sentinel lymph node procedure in patients with vulvar cancer: results of a multicenter study in Germany. Gynecol Oncol 2008; 111: 282
  • 15 Oonk MH, van Hemel BM, Hollema H et al. Size of sentinel-node metastasis and chances of non-sentinel-node involvement and survival in early stage vulvar cancer: results from GROINSS-V, a multicentre observational study. Lancet Oncol 2010; 11: 646
  • 16 Manavi M, Berger A, Kucera E et al. Does T1, N0-1 vulvar cancer treated by vulvectomy but not lymphadenectomy need inguinofemoral radiation?. Int J Radiat Oncol Biol Phys 1997; 38: 749-753
  • 17 Perez CA, Grigsby PW, Chao C et al. Irradiation in carcinoma of the vulva: factors affecting outcome. Int J Radiat Oncol Biol Phys 1998; 42: 335-344
  • 18 Stehman FB, Bundy BN, Thomas G et al. Groin dissection versus groin radiation in carcinoma of the vulva: a Gynecologic Oncology Group study. Int J Radiat Oncol Biol Phys 1992; 24: 389-396
  • 19 Katz A, Eifel PJ, Jhingran A et al. The role of radiation therapy in preventing regional recurrences of invasive squamous cell carcinoma of the vulva. Int J Radiat Oncol Biol Phys 2003; 57: 409-418
  • 20 Regauer S. Histopathological work-up and interpretation of sentinel lymph nodes removed for vulvar squamous cell carcinoma. Histopathology 2009; 55: 174
  • 21 Rahhal-Schupp J, Grimm C, Aust S et al. Prognostische Bedeutung des Serummarkers Gamma-Glutamyltransferase bei Patientinnen mit Vulvakarzinom. Geburtsh Frauenheilk 2012; 72 - A9
  • 22 Natter C, Rahhal J, Polterauer S et al. Einfluss der Lymphknotendichte auf das Gesamtüberleben bei Patientinnen mit Vulvakarzinom. Geburtsh Frauenheilk 2011; 71 - A12